New indications and formulations will make March a busy month for the US Food and Drug Administration, the Pink Sheet’s FDA Performance Tracker shows.
March Madness: Upcoming US FDA Decision Dates To Watch
A dozen applications for new drugs and significant new indications are on the US FDA’s calendar of goal dates, including breakthrough-designated applications from Bristol-Myers Squibb and Boehringer Ingelheim.
